Cancer News and Research

Latest Cancer News and Research

AI system can help detect the degree and severity of heart transplant rejection

Heart transplantation can be a lifesaving operation for patients with end-stage heart failure. However, many patients experience organ transplant rejection, in which the immune system begins attacking the transplanted organ.

21 Mar 2022

New form of MRI makes cancerous tissue to glow in medical images

A new form of magnetic resonance imaging (MRI) that makes cancerous tissue glow in medical images could help doctors more accurately detect and track the progression of cancer over time.

21 Mar 2022

20% of childhood AML cases associated with rare genetic changes inherited through family bloodlines

It's a diagnosis you never want to hear: Acute Myeloid Leukemia (AML). These three words represent a devastating diagnosis of childhood cancer with dire consequences for many families.

21 Mar 2022

Pandemic-related slowdown of cancer surgeries may impact patient survival

Pandemic-related slowdowns of cancer surgeries may result in shorter survival rates for patients with cancer, according to a new modeling study published in CMAJ.

21 Mar 2022

NIH launches Molecular Characterization Initiative for pediatric tumors

In support of President Biden's Cancer Moonshot℠ goal of fostering data sharing in cancer research, the National Cancer Institute, part of the National Institutes of Health, has launched the Molecular Characterization Initiative for pediatric tumors.

21 Mar 2022

Study reveals the extent of pandemic-related cancer screening deficits across the U.S.

Deaths from cancer are expected to increase over the next decade as a result of screening deficits due to the COVID-19 pandemic.

21 Mar 2022

Could sound waves help to regrow bones?

In this interview, we speak to Dr. Amy Gelmi and Professor Leslie Yeo about their new research that looked at using sound waves to regrow bones.

21 Mar 2022

Study explores prevalence and symptom trajectory of long COVID

A new study estimated long-term COVID-19, or, long COVID, and the trajectory of disease symptoms in a representative sample in the US.

21 Mar 2022

Sectra signs digital pathology contract with Erasmus MC

International medical imaging IT and cybersecurity company Sectra has signed a digital pathology contract with Erasmus University Medical Center (Erasmus MC) in the Netherlands.

21 Mar 2022

Study unveils several natural marine products as potential agents against SARS-CoV-2

A recent study, published in the Journal of Natural Products of the American Chemical Society and American Society of Pharmacognosy, highlighted three natural marine products as potent inhibitors of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – without any apparent toxic effects for human lung cells.

21 Mar 2022

Novel device uses tiny worms to detect lung cancer cells

Dogs can use their incredible sense of smell to sniff out various forms of cancer in human breath, blood and urine samples.

20 Mar 2022

UT Dallas researchers explore origins of chronic pain and the potential for better treatments

An investigation into how human nerve cells differ from animal cells has provided researchers from The University of Texas at Dallas' Center for Advanced Pain Studies with important clues in the pursuit of more effective treatments for chronic pain.

19 Mar 2022

Trial shows safety and immunogenicity of immunotherapy with chemoradiation in cervical cancer patients

A Phase I/Ib trial conducted by the National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group NRG Oncology, NRG-GY017, concluded that the addition of the immunotherapy drug atezolizumab prior to and concurrently given with chemoradiation (CRT) treatment was safe for women with node-positive, locally advanced cervical cancer.

19 Mar 2022

HRR mutational status associated with survival outcomes in recurrent platinum-sensitive ovarian cancer

Results of a biomarker analysis of the NRG Oncology NRG-GY004 trial were presented at a Seminal Session during the Society for Gynecologic Oncology's (SGO) Annual Meeting on Women's Cancer in March 2022.

19 Mar 2022

Combination therapy shows promising results in patients with recurrent ER-positive endometrial cancer

A combination therapy that targets cancer cells from within and without caused tumors to shrink or stabilize in 75% of patients with recurrent or persistent estrogen receptor- (ER-) positive endometrial cancer, results from a recent clinical trial show.

19 Mar 2022

Study finds significantly poorer outcomes among the youngest patients with brain tumor

A University of Colorado Cancer Center researcher has found, through extensive data analysis, that the youngest patients with brain tumors – those ages birth to 3 months – have about half the five-year survival rate as children ages 1 to 19.

18 Mar 2022

New discovery points to potential drug targets for ASXL1-mutant chronic myelomonocytic leukemia

New research from Mayo Clinic's Center for Individualized Medicine finds that patients with ASXL1-mutant chronic myelomonocytic leukemia - an uncommon type of cancer of the bone marrow - have distinctive epigenetic changes that can activate harmful genes and cause the cancer to grow faster.

18 Mar 2022

New 'Shared Commitments' set out priority actions across the UK to improve healthcare through genomics

The UK government, Welsh and Scottish Governments and Northern Ireland Assembly have today (Friday 18 march) agreed a series of commitments to improve outcomes for patients through better genomic testing and access to clinical trials.

18 Mar 2022

Urgent action needed to stem the rising trend of obesity in Africa

Urgent measures such as taxes and restrictions on sugary foods and drinks are needed to stem the rising trend of obesity in Africa, the World Health Organization (WHO) has warned.

18 Mar 2022

New approach radically increases the success of breast cancer immunotherapy

A study published in the journal Nature Cancer, carried out within the Cancer Programme at the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) by the Cancer Stem Cells and Metastasis Dynamics Laboratory, led by Dr. Toni Celià-Terrassa, and the Laboratory of Molecular Cancer Therapy, coordinated by Dr. Joan Albanell, with the participation of international centers, has discovered an approach that radically increases the success of immunotherapy in one of the most aggressive types of tumors, triple-negative breast cancer.

17 Mar 2022

Cancer News and Research

Latest Cancer News and Research

AI system can help detect the degree and severity of heart transplant rejection

New form of MRI makes cancerous tissue to glow in medical images

20% of childhood AML cases associated with rare genetic changes inherited through family bloodlines

Pandemic-related slowdown of cancer surgeries may impact patient survival

NIH launches Molecular Characterization Initiative for pediatric tumors

Study reveals the extent of pandemic-related cancer screening deficits across the U.S.

Could sound waves help to regrow bones?

Study explores prevalence and symptom trajectory of long COVID

Sectra signs digital pathology contract with Erasmus MC

Study unveils several natural marine products as potential agents against SARS-CoV-2

Novel device uses tiny worms to detect lung cancer cells

UT Dallas researchers explore origins of chronic pain and the potential for better treatments

Trial shows safety and immunogenicity of immunotherapy with chemoradiation in cervical cancer patients

HRR mutational status associated with survival outcomes in recurrent platinum-sensitive ovarian cancer

Combination therapy shows promising results in patients with recurrent ER-positive endometrial cancer

Study finds significantly poorer outcomes among the youngest patients with brain tumor

New discovery points to potential drug targets for ASXL1-mutant chronic myelomonocytic leukemia

New 'Shared Commitments' set out priority actions across the UK to improve healthcare through genomics

Urgent action needed to stem the rising trend of obesity in Africa

New approach radically increases the success of breast cancer immunotherapy

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in